152 related articles for article (PubMed ID: 8562928)
1. Analysis of the Bruton's tyrosine kinase gene promoter reveals critical PU.1 and SP1 sites.
Himmelmann A; Thevenin C; Harrison K; Kehrl JH
Blood; 1996 Feb; 87(3):1036-44. PubMed ID: 8562928
[TBL] [Abstract][Full Text] [Related]
2. Cell specific expression of human Bruton's agammaglobulinemia tyrosine kinase gene (Btk) is regulated by Sp1- and Spi-1/PU.1-family members.
Müller S; Sideras P; Smith CI; Xanthopoulos KG
Oncogene; 1996 Nov; 13(9):1955-64. PubMed ID: 8934542
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulatory elements within the first intron of Bruton's tyrosine kinase.
Rohrer J; Conley ME
Blood; 1998 Jan; 91(1):214-21. PubMed ID: 9414287
[TBL] [Abstract][Full Text] [Related]
4. Synergistic activation of the human Btk promoter by transcription factors Sp1/3 and PU.1.
Müller S; Maas A; Islam TC; Sideras P; Suske G; Philipsen S; Xanthopoulos KG; Hendriks RW; Smith CI
Biochem Biophys Res Commun; 1999 Jun; 259(2):364-9. PubMed ID: 10362515
[TBL] [Abstract][Full Text] [Related]
5. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA).
Zhu Q; Zhang M; Rawlings DJ; Vihinen M; Hagemann T; Saffran DC; Kwan SP; Nilsson L; Smith CI; Witte ON; Chen SH; Ochs HD
J Exp Med; 1994 Aug; 180(2):461-70. PubMed ID: 7519238
[TBL] [Abstract][Full Text] [Related]
6. Genomic organization of mouse and human Bruton's agammaglobulinemia tyrosine kinase (Btk) loci.
Sideras P; Müller S; Shiels H; Jin H; Khan WN; Nilsson L; Parkinson E; Thomas JD; Brandén L; Larsson I
J Immunol; 1994 Dec; 153(12):5607-17. PubMed ID: 7989760
[TBL] [Abstract][Full Text] [Related]
7. The transcription factor Sp1 regulates the myeloid-specific expression of the human hematopoietic cell kinase (HCK) gene through binding to two adjacent GC boxes within the HCK promoter-proximal region.
Hauses M; Tönjes RR; Grez M
J Biol Chem; 1998 Nov; 273(48):31844-52. PubMed ID: 9822652
[TBL] [Abstract][Full Text] [Related]
8. Identification of phosphorylation sites for Bruton's tyrosine kinase within the transcriptional regulator BAP/TFII-I.
Egloff AM; Desiderio S
J Biol Chem; 2001 Jul; 276(30):27806-15. PubMed ID: 11373296
[TBL] [Abstract][Full Text] [Related]
9. Binding of Sp1 to the proximal promoter links constitutive expression of the human uPA gene and invasive potential of PC3 cells.
Ibañez-Tallon I; Ferrai C; Longobardi E; Facetti I; Blasi F; Crippa MP
Blood; 2002 Nov; 100(9):3325-32. PubMed ID: 12384434
[TBL] [Abstract][Full Text] [Related]
10. Role of Bruton's tyrosine kinase in B cells and malignancies.
Pal Singh S; Dammeijer F; Hendriks RW
Mol Cancer; 2018 Feb; 17(1):57. PubMed ID: 29455639
[TBL] [Abstract][Full Text] [Related]
11. NF-kappaB regulates the transcription of protein tyrosine kinase Tec.
Yu L; Simonson OE; Mohamed AJ; Smith CI
FEBS J; 2009 Nov; 276(22):6714-24. PubMed ID: 19843184
[TBL] [Abstract][Full Text] [Related]
12. Regulation of nucleocytoplasmic shuttling of Bruton's tyrosine kinase (Btk) through a novel SH3-dependent interaction with ankyrin repeat domain 54 (ANKRD54).
Gustafsson MO; Hussain A; Mohammad DK; Mohamed AJ; Nguyen V; Metalnikov P; Colwill K; Pawson T; Smith CI; Nore BF
Mol Cell Biol; 2012 Jul; 32(13):2440-53. PubMed ID: 22527282
[TBL] [Abstract][Full Text] [Related]
13. Bruton's tyrosine kinase regulates immunoglobulin promoter activation in association with the transcription factor Bright.
Rajaiya J; Hatfield M; Nixon JC; Rawlings DJ; Webb CF
Mol Cell Biol; 2005 Mar; 25(6):2073-84. PubMed ID: 15743806
[TBL] [Abstract][Full Text] [Related]
14. Regulation of nuclear localization and transcriptional activity of TFII-I by Bruton's tyrosine kinase.
Novina CD; Kumar S; Bajpai U; Cheriyath V; Zhang K; Pillai S; Wortis HH; Roy AL
Mol Cell Biol; 1999 Jul; 19(7):5014-24. PubMed ID: 10373551
[TBL] [Abstract][Full Text] [Related]
15. Activation of Bruton's tyrosine kinase (BTK) by a point mutation in its pleckstrin homology (PH) domain.
Li T; Tsukada S; Satterthwaite A; Havlik MH; Park H; Takatsu K; Witte ON
Immunity; 1995 May; 2(5):451-60. PubMed ID: 7538439
[TBL] [Abstract][Full Text] [Related]
16. Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLA.
Gaspar HB; Lester T; Levinsky RJ; Kinnon C
Clin Exp Immunol; 1998 Feb; 111(2):334-8. PubMed ID: 9486400
[TBL] [Abstract][Full Text] [Related]
17. Naturally occurring Bruton's tyrosine kinase mutations have no dominant negative effect in an X-linked agammaglobulinaemia cellular model.
Pérez de Diego R; López-Granados E; Rivera J; Ferreira A; Fontán G; Bravo J; García Rodríguez MC; Bolland S
Clin Exp Immunol; 2008 Apr; 152(1):33-8. PubMed ID: 18241233
[TBL] [Abstract][Full Text] [Related]
18. An exon-skipping mutation in the btk gene of a patient with X-linked agammaglobulinemia and isolated growth hormone deficiency.
Duriez B; Duquesnoy P; Dastot F; Bougnères P; Amselem S; Goossens M
FEBS Lett; 1994 Jun; 346(2-3):165-70. PubMed ID: 8013627
[TBL] [Abstract][Full Text] [Related]
19. Sp1 and C/EBP are necessary to activate the lactoferrin gene promoter during myeloid differentiation.
Khanna-Gupta A; Zibello T; Simkevich C; Rosmarin AG; Berliner N
Blood; 2000 Jun; 95(12):3734-41. PubMed ID: 10845904
[TBL] [Abstract][Full Text] [Related]
20. Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan.
Hashimoto S; Tsukada S; Matsushita M; Miyawaki T; Niida Y; Yachie A; Kobayashi S; Iwata T; Hayakawa H; Matsuoka H; Tsuge I; Yamadori T; Kunikata T; Arai S; Yoshizaki K; Taniguchi N; Kishimoto T
Blood; 1996 Jul; 88(2):561-73. PubMed ID: 8695804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
